Last updated on April 2019

A Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of baricitinib as monotherapy in participants with moderate to severe atopic dermatitis.

Clinical Study Identifier: NCT03334396

Contact Investigators or Research Sites near you

Start Over

Centre Hospitalier Lyon Sud

Pierre Benite Cedex, France
  Connect »

Universit tsklinikum Freiburg

Freiburg im Breisgau, Germany
  Connect »

ISA GmbH

Berlin, Germany
  Connect »

Gandhi Hospital

Secunderabad, India
  Connect »

Hospital de Jesus

Mexico City, Mexico
  Connect »

JM Research S.C.

Cuernavaca, Mexico
  Connect »

LLC ArsVitae NorthWest

Saint-Petersburg, Russian Federation
  Connect »

LLC Medical Center "Kurator"

Saint-Petersburg, Russian Federation
  Connect »

SPb SBHI Skin-venerologic dispensary #10

St. Petersburg, Russian Federation
  Connect »

Gemeinschaftspraxis Mahlow

Blankenfelde-Mahlow, Germany
  Connect »

Fumimori Clinic

Fukuoka-shi, Japan
  Connect »

Kume Clinic

Nishi-ku Sakai-shi, Japan
  Connect »

Shirasaki Clinic

Takaoka-shi, Japan
  Connect »

CHU Grenoble Alpes

Grenoble Cédex 9, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.